The Association Between Genetic Variants in ACE1and ACE2 Genes with Susceptibility to COVID-19 Infection

Biochem Genet. 2024 Dec;62(6):4679-4692. doi: 10.1007/s10528-024-10722-8. Epub 2024 Feb 13.

Abstract

Angiotensin-converting enzyme 2 (ACE2) receptors facilitate the entry of the causative virus severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) into target cells. Some ACE gene variants have been suggested to be involved in COVID-19 pathogenesis. So, the aim was to assess the association between ACE1 rs4646994 and ACE2 rs2285666 genes polymorphisms and the susceptibility and severity of COVID-19. This case-control study was conducted on 197 patients with COVID-19 and 197 healthy controls. ACE-1 insertion/deletion (I/D) (rs4646994) and ACE2 rs2285666 genes polymorphisms were determined by the amplification refractory mutation system- polymerase chain reaction (ARMS-PCR) technique. The DD genotype of ACE1 I/D polymorphism was associated with increased susceptibility to COVID-19 infection (p = 0.012), whereas the ID genotype of this polymorphism was associated with decreased susceptibility (p = 0.003) (significance level = 0.017). There was no significant association in allele and genotype distribution of ACE2 rs2285666 polymorphism between cases and controls. The ACE1 I/D polymorphism may be considered as a risk factor for COVID-19 susceptibility.

Keywords: Angiotensin-converting enzyme 2; COVID-19; Iran; Polymorphism; SARS-CoV-2.

MeSH terms

  • Adult
  • Aged
  • Angiotensin-Converting Enzyme 2* / genetics
  • COVID-19* / genetics
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A* / genetics
  • Polymorphism, Single Nucleotide
  • SARS-CoV-2*

Substances

  • Angiotensin-Converting Enzyme 2
  • ACE2 protein, human
  • Peptidyl-Dipeptidase A
  • ACE protein, human